$AMAG, $AVTR, $DLTR, $ENDP, $FB, $NBEV
Daily HeffX-LTN reviews dozens of the Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.
Below is a list of The Street’s Key analysts outlook for Key issues for Wednesday follows:
AMAG Pharmaceuticals Inc. (NASDAQ:AMAG) was started as Overweight with a 19 target price at Barclays.
Avantor Inc. (NYSE:AVTR) was started as Buy and assigned a $20 target price at Goldman Sachs. Avantor was also UBS assigned a 21 target price and has a new Buy rating. KeyBanc Capital Markets assigned a Sector Weight rating, while Deutsche Bank started the stock at Buy. The initial IPO priced at 14 for 205-M/shares, with the original offering indicated at 154-M/ shares but in an 18 to 21 range.
Dollar Tree Inc. (NASDAQ:DLTR) was raised to Overweight from Neutral with a 122 price target at JPMorgan, with the firm noting that it has good metrics and sees improvements being implemented for consumers at its Family Dollar chain. The stock has a 52-wk trading range of 78.78 – 111.61 and a consensus target price at 111.40.
Endo International PLC (NASDAQ:ENDP) was started as Equal Weight and assigned a 6 target price at Barclays.
Facebook Inc. (NASDAQ:FB) was raised to Buy from Neutral at Moffett Nathanson, with the upgrade noting that multiple concerns of the firm from last year now have been addressed and are being worked through. It has a 52-wk trading range of 123.02 – 218.62 and a consensus target price at 221.50.
New Age Beverages Corp. (NASDAQ:NBEV) was started with a Buy rating and assigned a 9 target price at Compass Point.
Latest posts by Paul Ebeling (see all)
- The 5 Safest Cities in the World - October 13, 2019
- Box Office: ‘Joker’ Laughs with another $55-M in North America - October 13, 2019
- US Q-3 Earnings, Here They Come - October 13, 2019